Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 2 fuera de 5 páginas
Examen

NR 566 week 4 Questions & Answers 100% Correct!

Document preview thumbnail
Vista previa 2 fuera de 5 páginas

treatment of obesity: evaluation of phentermine/topiramate - ANSWER Schedule IV drug indicated for chronic weight loss. Phetermine suppresses appetite which topirmate increses satiety. Most common side efrects are dry mouth, constipation, blurred vision, and numbness tingling. -serious effects are memory loss, concentration, HTN, tachycardia, hypoglycemia treatment of obesity: evaluation of phentermine/topiramate contraindications: - ANSWER Glaucoma or hyperthyroid -Should not be given with MAOI. Stop MAOI 2 weeks before starting. -Carbonic anhydrase increases risk for metabolic acidosis -diuretics that are not K+ sparing increases risk for hyperkalemia Orlistat (Xenical) contraindications - ANSWER Malabsorption syndrome and cholestasis Lorcaserin (Belviq) - ANSWER weight loss drug Lorcaserin adverse effects - ANSWER HA, back pain, decrease lymphocytes and URIs, hypoglycemia in diabetics Lorcaserin adverse reactions that are less common - ANSWER Blood dye radios, cognitive impairment, psychiatric disorders, priapism, HTN, valvular heart disease Weight loss drugscontraindications for children - ANSWER Not recommended. - orlistat is not approved for kids under 12 Diethylpropion and phentermine are not for children under 16 Orlistat (Xenical) - ANSWER - Is prescribed to morbidly obese pts to lose weight. It prevents

Vista previa del contenido

NR 566 week 4 Questions &
Answers 100% Correct!
treatment of obesity: evaluation of phentermine/topiramate - ANSWER Schedule IV drug indicated
for chronic weight loss. Phetermine suppresses appetite which topirmate increses satiety. Most
common side efrects are dry mouth, constipation, blurred vision, and numbness tingling.

-serious effects are memory loss, concentration, HTN, tachycardia, hypoglycemia



treatment of obesity: evaluation of phentermine/topiramate contraindications: - ANSWER Glaucoma
or hyperthyroid

-Should not be given with MAOI. Stop MAOI 2 weeks before starting.

-Carbonic anhydrase increases risk for metabolic acidosis

-diuretics that are not K+ sparing increases risk for hyperkalemia



Orlistat (Xenical) contraindications - ANSWER Malabsorption syndrome and cholestasis



Lorcaserin (Belviq) - ANSWER weight loss drug



Lorcaserin adverse effects - ANSWER HA, back pain, decrease lymphocytes and URIs, hypoglycemia
in diabetics



Lorcaserin adverse reactions that are less common - ANSWER Blood dye radios, cognitive
impairment, psychiatric disorders, priapism, HTN, valvular heart disease



Weight loss drugscontraindications for children - ANSWER Not recommended.

- orlistat is not approved for kids under 12

Diethylpropion and phentermine are not for children under 16



Orlistat (Xenical) - ANSWER - Is prescribed to morbidly obese pts to lose weight. It prevents
absorption of some of the fat in the pts diet.

, - The med should be taken 3 times/day within 1 hour of a meal



- Its a lipase inhibitor, not an appetite suppressor.



Nalrexone (ReVia) - ANSWER Decrease the ability opioid analgesics to relieve pain

-do not take within 2 weeks of a MAOI



Naltrexone/Bupropion (Contrave) adverse reactions - ANSWER N/v, constipation, HA, dizziness, and
insomnia, increase blood pressure, dry mouth, diarrhea, and discomfort, anxiety, and fatigue, SI
thoughts



Naltrexone/Bupropion (Contrave) black box - ANSWER SI, SI attempts in children, adolescents, and
young adults



Naltrexone/Bupropion (Contrave) contradictions - ANSWER Taking other bupropion

Pts with uncontrolled HTN, seizure disorder, eating disorders such as anorexia or bulimia

-those going through alcohol, barbiturate, or benzodiazepine withdrawal



Orlistat (Xenical) drug interactions - ANSWER Levothyroxine- may cause hypothyroidism by
decreasing the absorption of thyroid hormone. If drug is needed take them 4 hrs apart

-cyclosporine- can reduce absorption, give them 2-3 hrs apart



Baseline data: Liraglutide - ANSWER HB A1C, lipids, renal function

Assessment of the one administering the injection



ongoing assessment for Liraglutide - ANSWER HBA1C every 6 months

Triglycerides

Assess s/s of cholecystitis, pancreatitis, depression and SI thoughts



baseline data for orlistat - ANSWER None noted

Orlistat (Xenical) adverse effects: - ANSWER Oily rectal leakage, sharting, fecal urgency, and fatty or
oily stools

Información del documento

Subido en
10 de septiembre de 2024
Número de páginas
5
Escrito en
2024/2025
Tipo
Examen
Contiene
Preguntas y respuestas
$15.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
Exampool
3.9
(32)
Vendido
224
Seguidores
148
Artículos
3589
Última venta
4 semanas hace



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes